Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide?

Item

http://www.wikidata.org/entity/Q36366988

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@ast

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@en

type

Item

label

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@ast

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@en

prefLabel

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@ast

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@en

P1476

Myelodysplasia-associated immu ...... they induced by lenalidomide?

@en

P2093

Alberto Orfao

http://www.w3.org/2001/XMLSchema#string

Bruno Paiva

http://www.w3.org/2001/XMLSchema#string

Estefanía Pérez

http://www.w3.org/2001/XMLSchema#string

GEM Grupo Español de MM/Progra ...... gnas Co-operative Study Groups

http://www.w3.org/2001/XMLSchema#string

Lucia López-Corral

http://www.w3.org/2001/XMLSchema#string

Maria-Victoria Mateos

http://www.w3.org/2001/XMLSchema#string

Miguel T Hernández

http://www.w3.org/2001/XMLSchema#string

Pilar Giraldo

http://www.w3.org/2001/XMLSchema#string

P2860

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)

Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.

Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised p

Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.

Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.

P304

1608-1611

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3324/HAEMATOL.2012.064121

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sergio Matarraz

Jesus San Miguel

Maria Diez-Campelo

P577

2012-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224284803

http://www.w3.org/2001/XMLSchema#string

P698

22511492

http://www.w3.org/2001/XMLSchema#string

P932

3487564

http://www.w3.org/2001/XMLSchema#string